727. Deputy Seán Fleming asked the Minister for Health when spinal muscular atrophy drug treatment will be made available to adults suffering with spinal muscular atrophy (details supplied); and if she will make a statement on the matter. [13563/25]
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
796. Deputy Sinéad Gibney asked the Minister for Health for an update on the issue of hormone replacement therapy (HRT) medication shortages; the steps her Department is taking to address these shortages and mitigate the disruption to those who need HRT medication; and if she will make a statement on the matter. [13900/25]
797. Deputy Sinéad Gibney asked the Minister for Health if women using hormone replacement therapy (HRT) will be reimbursed for costs incurred due to the delay of the free HRT scheme; and if she will make a statement on the matter. [13901/25]
811. Deputy Ken O'Flynn asked the Minister for Health to provide clarification regarding the rollout of free hormone replacement treatment for all women, which was due to be implemented in January 2025 (details supplied). [13965/25]
479. Deputy Michael Healy-Rae asked the Minister for Health if the medicine Mounjaro will be offered on the medical card or long-term illness card (details supplied); and if she will make a statement on the matter. [13200/25]
1510. Deputy Shane Moynihan asked the Minister for Health the measures being taken to improve the availability and supply of Creon (pancreatic enzymes) to Ireland. [10766/25]
1665. Deputy Seán Ó Fearghaíl asked the Minister for Health the reason for the shortage of certain medicines (details supplied); and if she will make a statement on the matter. [11508/25]
1690. Deputy John Brady asked the Minister for Health if consideration will be given to implementing a reimbursement scheme through the medical card and or drugs payment scheme for Ozempic; and if she will make a statement on the matter. [11650/25]
1755. Deputy Marie Sherlock asked the Minister for Health if durvalumab is being considered for use by the HSE as part of the first-line treatment of patients with cholangiocarcinoma (bile duct cancer) as is now the case in the United Kingdom; and if she will make a statement on the matter. [11901/25]
1866. Deputy Grace Boland asked the Minister for Health when she intends to launch the review into Ireland's reimbursement process; and if she will make a statement on the matter. [12554/25]
1869. Deputy Grace Boland asked the Minister for Health if she intends to review how orphan medicinal products are assessed and reimbursed as part of the Programme for Government's commitment to conduct a review into Ireland's reimbursement process; and if she will make a statement on the matter. [12557/25]
1870. Deputy Grace Boland asked the Minister for Health if the upcoming Rare Disease Strategy will provide recommendations/actions on how to improve Ireland's reimbursement process for innovative treatments for rare disease patients; and if she will make a statement on the matter. [12558/25]
1871. Deputy Grace Boland asked the Minister for Health the steps she will take to implement the Programme for Government's commitment to introduce early access/interim access schemes for patients who require urgent access to EMA-approved treatments in advance of a decision to reimburse the treatment in Ireland; and if she will make a statement on the matter. [12559/25]
119. Deputy Peter Roche asked the Minister for Health the measures being taken to address the rising costs of prescription medicines in Ireland; if she has considered introducing additional supports or subsidies to alleviate the financial burden on patients; the steps being implemented to improve the availability of essential medicines; if a more sustainable model will be introduced; and if she will make a statement …
166. Deputy Aindrias Moynihan asked the Minister for Health the up-to-date position on a medication (details supplied) to be made available through the drugs payment scheme; and if she will make a statement on the matter. [10121/25]
162. Deputy David Cullinane asked the Minister for Health to provide an update on the funded HRT scheme announced in Budget 2025; what discussions her officials have had with the Irish Pharmacy Union in relation to the scheme; and if she will make a statement on the matter. [9853/25]
163. Deputy David Cullinane asked the Minister for Health if she will provide an update on whether injectable semaglutide medicines will be made available to obesity patients on the drugs payment scheme before the end of the year; and if she will make a statement on the matter. [9854/25]
164. Deputy David Cullinane asked the Minister for Health if she is aware of the ongoing shortage of prescription packs (60 tablets) of soluble Solpadine, not to be confused with the over-the-counter packs available without prescription available in 12 and 24 tablets; if officials from her Department have discussed the shortage with the HPRA or manufacturer; and if she will make a statement on the matter. [9855/25]
165. Deputy David Cullinane asked the Minister for Health to provide an update on the timeline for the introduction of pharmacist prescribing; what recommendations from the expert taskforce have been achieved so far; and if she will make a statement on the matter. [9857/25]
185. Deputy Colm Burke asked the Minister for Health if she will consider reducing the threshold of the drugs payment scheme to €72 per month, as per the 2017 Sláintecare report; and if she will make a statement on the matter. [9954/25]
194. Deputy Ryan O'Meara asked the Minister for Health for an update on the rollout of the hormone replacement therapy programme, with specific regard to the ongoing discussions regarding dispensing fees; and if she will make a statement on the matter. [10023/25]
707. Deputy James Geoghegan asked the Minister for Health if the 34 new whole-time equivalent positions for the agencies involved in the HSE’s medicines pricing and reimbursement system, as initially prescribed in February 2023, have now been successfully filled; whether they have commenced their engagement; and if she will make a statement on the matter. [9516/25]
713. Deputy Catherine Connolly asked the Minister for Health further to Parliamentary Question No. 1086 of 5 February 2024, when hormone replacement therapy will be freely available to those with a prescription; and if she will make a statement on the matter. [9540/25]
754. Deputy Peter 'Chap' Cleere asked the Minister for Health the reason buscopan RX has been removed from the general medical scheme/medical card scheme; and if she will make a statement on the matter. [9647/25]
778. Deputy Mary Lou McDonald asked the Minister for Health if she intends to review the terms of the drugs payment scheme; if she will extend the long-term illness scheme in order to include rheumatoid arthritis as a long-term chronic illness; and if she will make a statement on the matter. [9782/25]